GleamWall
中文EN

CDIO Cardio Diagnostics Holdings, Inc.

In Vitro & In Vivo Diagnostic Substances · Nasdaq · SEC CIK 1870144 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-3.8%
TTM net income YoY1.0%
TTM EPS YoY21.0%
Revenue 3-yr CAGR6.1%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-42,649.8%
Net margin-42,721.9%
FCF margin-38,090.8%
EBITDA margin-42,499.9%

Returns

ROE-93.5%
ROA-87.2%
ROIC (approx.)-136.2%
Asset turnover0.00x

Leverage & solvency

Liabilities / assets6.0%
Debt / equity0.00x
Current ratio17.44x
Interest coverage-564.93x

Cash quality & payout

Operating cash flow / net income0.89x
Accruals ratio-9.5%
Payout ratio—
Capex / revenue11.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$14,825$34,890
R&D expense$641,212$227,966
SG&A expense$5.03M$6.92M
Operating income-$6.48M-$8.37M
Interest expense$14,801$18,640
Pretax income-$6.50M-$8.38M
Net income-$6.50M-$8.38M
EBITDA-$6.42M-$8.35M
EPS (basic)-3.71-9.35
EPS (diluted)-3.71-9.35
Weighted avg. shares (diluted)1.75M896,424
Balance sheet
Cash & equivalents$0$7.83M
Receivables$8,126$18,612
Current assets$5.92M$8.79M
PP&E, net$700,115$672,861
Intangibles—$5,333
Total assets$7.77M$10.62M
Current liabilities$604,839$631,695
Total liabilities$793,061$1.06M
Shareholders' equity$6.97M$9.56M
Shares outstanding1.83M1.53M
Cash flow statement
Operating cash flow-$5.73M-$4.99M
Capital expenditure$187,317$214,765
Free cash flow-$5.91M-$5.21M
Investing cash flow-$419,310-$404,190
Financing cash flow$3.43M$11.94M
Depreciation & amortization$65,233$19,738
Stock-based compensation$110,235$2.59M

Free plan shows the latest 2 periods; Pro shows all 5 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.